These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 648812

  • 1. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn HO, Felig P.
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [Abstract] [Full Text] [Related]

  • 5. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
    Sherwin R, Joshi P, Hendler R, Felig P, Conn HO.
    N Engl J Med; 1974 Jan 31; 290(5):239-42. PubMed ID: 4808927
    [No Abstract] [Full Text] [Related]

  • 6. Glucagon and insulin metabolism in cirrhotic patients.
    Yoshida T, Ninomiya K, Matsumoto T, Baatar D, Bandoh T, Kitano S.
    Hepatogastroenterology; 1998 Jan 31; 45(20):468-71. PubMed ID: 9638429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL, Resnick RH, Koff RS, Ros E, Baum RA, Pallotta JA.
    Gastroenterology; 1977 Feb 31; 72(2):301-4. PubMed ID: 830579
    [Abstract] [Full Text] [Related]

  • 9. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM, Eisenstein AB, Tucci J, Pellicone J.
    Am J Gastroenterol; 1984 Feb 31; 79(2):143-9. PubMed ID: 6364796
    [Abstract] [Full Text] [Related]

  • 10. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G, Forlani G, Angiolini A, Zoli M, Scolari MP, Bianchi FB, Pisi E.
    Diabete Metab; 1979 Jun 31; 5(2):135-9. PubMed ID: 478083
    [Abstract] [Full Text] [Related]

  • 11. Hormonal and metabolic changes in hepatic cirrhosis.
    Johnston DG, Alberti KG, Binder C, Faber OK, Wright R, Orskov H.
    Horm Metab Res; 1982 Jan 31; 14(1):34-9. PubMed ID: 7037586
    [Abstract] [Full Text] [Related]

  • 12. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
    Dupre J, Caussignac Y, McDonald TJ, Van Vliet S.
    J Clin Endocrinol Metab; 1991 Jan 15; 72(1):125-9. PubMed ID: 1986010
    [Abstract] [Full Text] [Related]

  • 14. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O.
    Dan Med Bull; 1997 Jun 15; 44(3):225-41. PubMed ID: 9233544
    [Abstract] [Full Text] [Related]

  • 15. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E, Barazzoni R, Tessari P.
    Diabetes Nutr Metab; 2001 Dec 15; 14(6):315-24. PubMed ID: 11853363
    [Abstract] [Full Text] [Related]

  • 16. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A, Contini S, Bonora E, Marni A, Colotto G, Capocasale E, Butturini U.
    Diabete Metab; 1986 Aug 15; 12(4):197-202. PubMed ID: 3533668
    [Abstract] [Full Text] [Related]

  • 17. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP, Solomon SS, Duckworth WC, Himmelstein S, Gray S, Jerkins T, Bobal MA, Iyer RS.
    J Lab Clin Med; 1983 Oct 15; 102(4):459-69. PubMed ID: 6352838
    [Abstract] [Full Text] [Related]

  • 18. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ, Dupre J, Caussignac Y, Radziuk J, Van Vliet S.
    Metabolism; 1979 Apr 15; 28(4):300-7. PubMed ID: 449682
    [Abstract] [Full Text] [Related]

  • 19. [Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].
    Marchesini G, Zoli M, Dondi C, Angiolini A, Forlani G, Melli A, Bianchi FB, Pisi E.
    Gastroenterol Clin Biol; 1982 Mar 15; 6(3):272-8. PubMed ID: 7047286
    [No Abstract] [Full Text] [Related]

  • 20. [Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
    Vetter D, Fratte S, Winiszewski P, Reville M, Hirsch E, Roze F, Blickle JF, Pinget M, Doffoel M, Bockel R.
    Gastroenterol Clin Biol; 1990 Mar 15; 14(5):483-91. PubMed ID: 2194890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.